2022-09-08 14:48
浏览:27次
分享:资料摘要:
药物经皮渗透分析与评估系统
型号: KX-TTS-CAD
产地:
品牌: 科翔科技
面议
参考报价
全自动透皮扩散系统
型号: KX-ADP-V24
产地:
品牌: 科翔科技
¥ 50万 - 100万
参考报价
下载本篇资料:
相关资料
透皮制剂研发的热潮催生了涂布机市场,目前高端的中试涂布机、生产型涂布机仍然是以高价的欧美、日本品牌为主,而随着国产替代的时代来临,科翔科技在透皮吸收实验室技术和设备的优势逐步被市场认可,其高性价比的智能中试涂布机逐渐的在高端市场占据一席之地,纷纷落户恒瑞制药、九典制药、新领先、红珊瑚….等制药企业。
制备了帕洛诺司琼透皮贴片并考察其体外释放和透过行为,以及在大鼠体内的药动学特征。分别采用 3 种不同类 型的含羟基丙烯酸压敏胶 (PSA-1、PSA-2 和 PSA-3) 制备出 F1、F2、F3 贴片,通过影响因素试验、体外释放和体外透 皮试验进行评价,筛选出优化贴片进行大鼠药动学试验。结果表明,处方 F2 中帕洛诺司琼的有关物质含量明显低于处 方 F1 和 F3,且帕洛诺司琼具有较快的释放速率及较高的体外透过能力,48 h 累积透过率达到 (78.8±11.6)%。F2 贴片的 大鼠药动学试验结果表明,贴片组比市售注射组有更长的消除半衰期 [ (26.4±6.8) h vs.(16.4±5.9) h],绝对生物利用度为 (33.1±13.2)%。因此,PSA-2 制备的帕洛诺司琼透皮贴片经皮给药的可行性较高。
目的:考察盐酸青藤碱(SNH)的经皮渗透性,并通过优化电致孔参数以达到对 SNH 最佳促渗 作用。方法:采用体外扩散池法研究 SNH 的经皮渗透性及电致孔的促渗作用,并通过小鼠在体试验进一步 评估电致孔的促渗效果。结果:在稳态条件下,SNH 在裸鼠去角质皮肤和全皮中的渗透速率分别为 (385.81±12.88),(0.88±0.20) μg·cm-2·h-1,去角质皮肤中的渗透速率约为全皮中的 438 倍;渗透动力学分 析结果表明,SNH 在角质层中的溶解度和扩散系数都比较低,分别为(70.82±9.63)×103 g·m-3 和(3.07±1.52) ×10-14 cm2·s-1;在优化的电致孔条件(电压 72 V,时间 60 min)下,SNH 在小鼠皮肤中的 24 h 累积渗透量达 到(10 008.39±1 961.57) μg·cm-2,稳态渗透速率达(456.01±51.26) μg·cm-2·h-1,与空白组相比分别提高了 5.4 倍和 5.1 倍,皮肤和肌肉中 SNH 的滞留量分别为空白组的 2.0 倍和 1.5 倍。结论:SNH 在角质层中较低 的溶解度和扩散系数是阻碍其经皮渗透的主要因素,电致孔可显著提高 SNH 的经皮渗透,并可以增加 SNH 在小鼠皮肤和肌肉中的滞留量。
Background: Glycyrrhetinic acid (GA) and paeoniflorin (PF) are the main active ingredients in Chinese peony- Liquorice Decoction, a widely used Traditional Chinese Medicine. Hypothesis/Purpose: The aim of this work was to investigate the combinatory analgesic effect of GA and PF after percutaneous administration and to define their pharmacokinetic/pharmacodynamic (PK/PD) characteristics. Study design and Methods: GA and PF were produced to transdermal patches based on previous research, and the permeation parameters of GA and PF in the patches were investigated with in vitro experiments. Dysmenorrhea model mice were then produced to compare the analgesic effects of the patches with different proportions of GA-PF. In the in vivo assessment, the number of writhes exhibited by the dysmenorrhea mice was recorded at designated time points, and skin, muscle under skin and plasma samples were collected, for assessments of drug distribution, pharmacokinetics parameters and PK/PD characteristics. Results and conclusion: In dysmenorrhea mice, GA-PF and meloxicam (the positive control drug) could relieve pain to equal degrees. Specifically, a single dose of the optimized patches (10%GA-10%PF, wt) exerted a steady analgesic effect for 48 h in dysmenorrhea mice, but this effect lagged behind the changes in the plasma concentration. Evaluation with the Bliss Independence criterion revealed that the two ingredients displayed a synergistic effect. Then the PK/PD relationship of GA in this compound preparation was defined with this synergistic effect. The preparation might be suitable for topical spasmolysis and anti-inflammatory therapy